Zhang Financial LLC raised its holdings in Tiziana Life Sciences Ltd (NASDAQ:TLSA – Free Report) by 34.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 93,187 shares of the company’s stock after buying an additional 23,800 shares during the quarter. Zhang Financial LLC owned 0.09% of Tiziana Life Sciences worth $65,000 as of its most recent SEC filing.
Separately, Sanctuary Advisors LLC acquired a new position in Tiziana Life Sciences during the third quarter worth $864,000.
Tiziana Life Sciences Price Performance
Shares of TLSA opened at $0.74 on Tuesday. The stock has a 50 day moving average price of $0.86 and a two-hundred day moving average price of $0.95. Tiziana Life Sciences Ltd has a 52 week low of $0.41 and a 52 week high of $1.74.
About Tiziana Life Sciences
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases.
Featured Articles
- Five stocks we like better than Tiziana Life Sciences
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- Canadian Penny Stocks: Can They Make You Rich?
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- Roth IRA Calculator: Calculate Your Potential Returns
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for Tiziana Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tiziana Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
